Cruz-Lopez EO, Ye D, Stolk DG, Clahsen-van Groningen MC, et al. Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects. J Hypertens 2023 Dec 11. doi: 10.1097/HJH.0000000000003633.
PMID: 38088400